Found 4 matching trials
An Eight-Week Study Evaluating the Efficacy of Two Fixed Doses (250 mg Twice Daily and 100 mg Twice Daily) of SSR149415 in Patients With Major Depressive Disorder PHASE2 The purpose of the study is to evaluate the efficacy of SSR149415 in the tr...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial
An Eight-Week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Major Depressive Disorder PHASE2 The objective is to evaluate the efficacy and safety of two doses of SSR149...
Show More Learn More & Join Trial
Evaluation of the Potential Effects of SSR149415 on the Hypothalamic-pituitary-adrenal Axis in Outpatients With Major Depressive Disorder PHASE2 Primary Objective:
\- To evaluate the effects of two fixed doses of SSR149...
Show More Learn More & Join Trial
An Eight-week Study Evaluating the Efficacy and Tolerability of Two Doses of SSR149415 in Outpatients With Generalized Anxiety Disorder PHASE2 The objective is to evaluate the efficacy and safety of two doses of SSR149...
Show More Location
Sanofi-Aventis Administrative Office
Learn More & Join Trial